• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    3-(1-Pyrazolyl)-pyridazine derivatives of the formula I, or pharmaceutically acceptable acid addition salts thereof, which decrease high blood pressure and inhibit catabolism or prostaglandins, <IMAGE> (I) wherein R1 is hydrogen or C1-4 alkyl, R2 is hydrogen, cyano, carboxyl, carbamoyl, carbaxoyl or C1-4 alkoxycarbonyl, R3 is hydrogen or chlorine or -NR4NHR5 or NR6R7, wherein R4 and R5 are each hydrogen or C1-4 alkyl, wherein R6 and R7 are each hydrogen or C1-5 alkyl, C1-5 hydroxyalkyl, C3-7 cycloalkyl, phenyl or benzyl, or benzyl or phenylethyl substituted with one or two chlorine atoms or methoxy groups, or a furylmethyl, pyridylmethyl, pyrrolidine or piperazine ring, or when R7 is hydrogen, R6 is -(CH2)n -NR4R5 wherein n is an integer from 1 to 3.
    公开号:SU797577A3
    申请号:SU782626901
    申请日:1978-06-12
    公开日:1981-01-15
    发明作者:Силадьи Геза；Кастрайнер Эндре；Тардош Ласло；Коша Эдит；Яслитш Ласло；Чех Дьердь；Дивалд Андраш；Толнаи Пал；Элек Шандор；Элекеш Иштван；Полгари Иштван
    申请人:Рихтер Гедеон Ведьесети Дьяр Рт(Инопредприятие)；
    IPC主号:
    专利说明:

    one
    This invention relates to a process for the preparation of novel 3- (pyrazol-1-yl) -; Pyridazine derivatives of the general formula
    /
    P..
    where And is a hydrogen atom or C | -C4-alkyl;
     cyan, carbamoyl; or C1-C4 alkoxycarbonyl;
    R-group of the formula NR —NHR, in which R and R - each of the radicals can be a hydrogen atom, the same or different C 1 -C 4 upsets, or the R-NR group in which R - each of the radicals could be a hydrogen atom, the same or different Ci-GS-alkyl or oxy-C 1 -C 5 -alkyl groups, C-CT-cycloalkyl groups, phenyl, benzyl, or substituted by one or two chlorine atoms or methoxy groups by beisyl, phenylethyl, furylmethyl
    pyridylmethyl ,. a pyrrolidylmethyl, or an N group means a morpholine, piperndine or piperazine ring, or when R is a hydrogen atom, R can be a - (CH2) nN Rn group, in which the R values are given above, or their pharmaceutically acceptable salts, which can be used in the pharmaceutical industry.
    A known method for producing pyrazole derivatives by the interaction of nitriles with hydrazines 1 ...
    The purpose of the invention is to develop, on the basis of a known method, a method of obtaining new compounds with valuable pharmaceutical properties.
    The goal is achieved by the method of obtaining compounds of the general formula (T), which consists in the fact that the compound of the general formula P
    c HjOel where R is as defined above; R is cyan or C-C alkoxycar is reacted with 6-chloro-3-pyridazinyl hydrazine and the resulting compound is: III where fi is as defined above; R is cyan or C -C-alkoxycarbonyl, if necessary, if R is a cyan group, it is hydrolyzed to a carbamoyl group, the resulting compound is reacted with a hydrazine of the general formula R NH-NH-R, where R values are given above, or reacted an amine of the general formula, where the values of R and R are given above, and the desired product is isolated in free form or in the form of a pharmaceutically acceptable salt. Example 1, 3- (4-Methyl-piperazin-1-yl) -6- (5-amino-4-ethoxycarbonyl-pyrazol-1-yl) pyridazine. A mixture of 5.36 g (20 mmol) of 3-chloro-6- (4-ethoxycarbonyl-4-amino-pyrazol-1-yl) pyridazine and 4.4 g (44 mol) of 4-methylpiperazine is heated for 6 hours at 150 ° C, then cooled and poured into water. The solid product is filtered and recrystallized from alcohol. The product yield is 4.8 g (73.5%), so pl. 150-151 ° C. In tab. 1 shows the 6- (4-ethoxycarbonyl-5-amino-pyrazol-bil) -pyridazine derivatives substituted at the 3-position, or their salts obtained by the method described above (preparative yield calculated on the basis of recrystallization). Table 1
    Bis- (hydroxyethyl) -amino
    Oxystilamino
    3,4-Dimethoxyphenyl-ethylamino
    Cyclohexylamino
    Furfurylamino
    Benzylamino
    Morpholino
    Cyclopropylamino
    4- (hydroxy ethylamino) piperazine-1-yl
    Diethylamine-ethylamino
    Phenylethylamine
    42.5 76
    69.5 96
    52.5
    62.5
    83
    64
    73
    62.5
    49
    176-179
    Prizamestitel in 3-position measures
    4-Chlorobenzyl-amino
    Cyclohexylmethylamino
    Aniline
    Pyrid-2-yl-methylamino
    Pyrid-3-yl-methylamino
    Pyrid-4-yl-methylamino
    4-methobeibenzyl-amino
    a-Phenylethylamino
    1-Ethyl-pyrolidin-2-yl-metsh1amio
    Melting point of hydrochloride.
    Example 22. 3-Chloro-5- (4-cyano-5-aminopyrazole-1-nl) -nridazine.
    A mixture of g (30 mmol) of 6-chloro-3-pyridaznyl-hydrazine, 3.96 g (30 mmol) of ethoxy-methylene-malononitrile, and 60 ml of ethanol is kept for 2 hours at boiling point. After cooling, the precipitated crystals are filtered, washed with ethanol and dried. The output of 5.85 g (88,5%), so pl. 250.252C.
    By the method described in Example 22, SO 3-chloro-6- (3-methyl-4-cyano-5-amino-pyridazrl-1-11l) -pyridazine is obtained, m.p. 296-299 ° C. The yield is 77.5%. .
    The yield indicated is preparative, i.e. in the calculation of the substance after crystallization.
    Example 23. 3-Chloro-6- (4-carbamoyl-5-am-55 nopyrazole-1-yl) pyridazine.
    3 g of 3-chloro-6- (4-cyano-5-amino-pyrazol-1-yl) shridazine obtained in Example 22, times (sewed at room temperature with 10.5 ml
    Output,
    M.p.
    84.5
    160-162
    concentrated sulfuric acid for 1 h. Then the reaction mass is poured onto ice, the precipitated precipitate is filtered off, washed with water, then shaken with 15 ml of boiling alcohol. 3.05 g (93.5%) of the above product are obtained, t. Sh1. 314-317 ° C.
    Example 24. 3-Hydrazino-6- (4-cyano-5-amino-pyrazol-1-yl) -pyridazine.
    A mixture of 10 g of 3-chloro-6- (4-cyano-5-amino-pyrazole-1-Sh1) -pyridazine (Example 22), 20 ml of dimethylformamide and 40 ml of 98% hydrazine hydrate is stirred for 5 hours at 90 95 ° C. After cooling, the reaction product is filtered off, washed first with water, then with alcohol, and finally stirred up with 50 ml of boiling alcohol. The product yield of 9.1 g (93%), so pl. 264-266 ° C, so pl. hlorgndrata 253-256 ° C.
    77975778
    In tab. 2 shows the compounds or salts by their desired method (the yield of products is indicated
    acid addition, obtained iredla-after over-crystallization (ii).
    Melting point of hydrochloride.
    Example 28. 3- (1-Methylhydrazino) -6 - (4-cyano-5-amino-pyrazol-1-yl) -pyridazine,
    A mixture of 2.2 g (10 mmol) 3-chloro-6- (4-cyano-5-amino-pyrazol-1-yl) -pyridazine (Example 22), 1.38 g (30 mmol) of methyl hydrazine and 35 ml of dimethylformand incubated for 7.5 hours at 120-130 ° C. After cooling, the reaction mixture is poured onto 60 ml of water. The precipitated crystals are filtered off, washed with water and shaken with 5 ml of hot alcohol.
    The yield of the target product is 2.1 (91%), so pl. (with decomposition.) 260 ° C.
    Arbitrary 3- (pyrazol-1-yl) -pyridazine synthesized lowers blood pressure and inhibits the function of enzymes that regulate catabolism.
    table 2
    in which R and each of the radicals can be a hydrogen atom, the same shsh different C-C-alkyl or hydroxy-C-Cj-alkyl groups, Cj-C-cycloalkyl groups, phenyl, benzyl, or substituted by one or two chlorine atoms or methoxy groups by benzyl, phenylsyl, furylmethyl, pyridylmethyl, pyrrolidyl methyl, or the group-ME gives rise to a morpholine, piperidine or piperazine ring, or when R is a hydrogen atom, R may be a group - (CH, 2) n MR R, in which the value R given above,, or their pharmaceutically acceptable salts, from because the compound of general formula IT
    权利要求:
    Claims (1)
    [1]
    Invention Formula
    The method of obtaining 3- (pyrazole-1-sh1) -pyridazin-derivatives of General formula I
    VNH
    g
    where K is a hydrogen atom or C-C4-alkyl;
     cyan, carbamoyl or C-Cd-alkoxycarbonyl;
    -NR -NHR
    R is a group of the formula
    in ko lj. .
    Jurassic R and R Each of the radicals can &amp; 1 hydrogen atom, same or different Ct-C4 alkyl, or R-group
    /
    WITH
    about CN
    Va
    H-
    R is as defined above;
    R is cyan or C —C zloxycarbonyl;
    is reacted with 6-chloro-3-niridazinyl hydrazine and the resulting compound of the general formula GP
    .AND
    where R is as defined above;
    R stands for cyan or C -C-alkoxycarbonyl, if necessary, if R stands for 9 797577IO
    em cyangroup, it is hydrolyzed to a carbamoyl-left product is isolated in free form.
    Noah groups, the resulting compound is subjected to in the form of a pharmaceutically acceptable
    interaction with hydrazine of the general formula salts.
    R is -NH-NH-R, where R values are sources of information,
    given above, or subject to interactions — j taken into account when examining
    with an amine of the general formula K —NH — MH — K, i. Heterocyclic compounds. Ed.
    where the values of R are given above, and ce-Elderfield. M., IL, .1961. v. 5, p. 102
    类似技术:
    公开号 | 公开日 | 专利标题
    SU797577A3|1981-01-15|Method of preparing 3-|-pyridazine derivatives or their pharmacetically employed salts
    RU2053230C1|1996-01-27|Method of synthesis of derivatives of aryl- or heteroarylpiperazinylbutylazole
    DE602004010848T2|2008-12-11|DERIVATIVES OF 1-PIPERAZINE AND 1-HOMOPIPERAZINE CARBOXYLATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INHIBITORS OF THE FAAH ENZYME
    HU220046B|2001-10-28|Pyrazolopyrimidinone derivatives, pharmaceutical compositions containing them and process for their preparation
    CA2475455A1|2003-08-28|Process for preparing indolinone derivatives
    Reiter et al.1986|On triazoles. V. Synthesis of 1‐and 2‐R1‐3‐R2, R3‐amino‐5‐amino‐1, 2, 4‐triazoles
    CA1271751A|1990-07-17|Dihydroimidazo[1,2-a]pyrimidine derivatives
    WO2006133634A1|2006-12-21|Tetrahydroindole derivatives and tetrahydroindazole derivatives, and use thereof
    US4014890A|1977-03-29|Process for preparing indole derivatives
    US3994893A|1976-11-30|4-Amino derivatives of pyrozolo[1,5-a]quinoxaline-3-carboxylic acid and esters
    US4666915A|1987-05-19|2-anilino-1,6-dihydro-6-oxo-5-pyrimidine-carboxylic acid derivatives, process for the preparation thereof, and antiallergic agent containing the same
    Graham et al.1949|Investigation of Pyrazole Compounds. VIII. 1 Synthesis and Acylation of Pyrazolones Derived from Hydrazine and Methylhydrazine
    JP3712619B2|2005-11-02|Catechol hydrazone derivative, production method and pharmaceutical composition containing the same
    SU847920A3|1981-07-15|Method of preparing derivatives of 3-|pyridazine or their salts with pharmacetically adopted scids
    US3337551A|1967-08-22|Heterocyclic amides of 2, 6-dioxo-4-piperidineacetic acid
    US3084165A|1963-04-02|Quinone derivatives and processes for producing the same
    SU867300A3|1981-09-23|Method of producing pyridazinylhydrazones or their salts with acids
    SE450120B|1987-06-09|NEW DIMETOXICINAZOLINE DERIVATIVES TO USE FOR PREPARATION OF 2 | -4-AMINO-6,7-DIMETOXICINAZOLINES
    Claramunt et al.2000|3 |-| pyrazoles: chemistry and molecular structure
    SU847924A3|1981-07-15|Method of preparing bisthiazole derivatives or their salts
    Takahashi et al.1974|The Synthesis of 1, 3, 4-Benzotriazepin-5-one Derivatives from Isatoic Anhydrides
    US4013658A|1977-03-22|Synthesis of 3,5-diphenyl-4|-pyridazinones
    HU197001B|1989-02-28|Process for producing new pyrazine derivatives and pharmaceuticals comprising same
    SU999967A3|1983-02-23|Process for producing 6-n-substituted 6-amino-3-pyridazinyl hydrizines or their salts
    US4022782A|1977-05-10|4-Piperazinyl derivatives of pyrazolo [1,5-a]-quinoxaline-3-carboxylic acids and esters
    同族专利:
    公开号 | 公开日
    FI64156B|1983-06-30|
    AT357548B|1980-07-10|
    FR2394542B1|1980-12-05|
    PL111252B1|1980-08-30|
    IL54816A|1981-09-13|
    US4251658A|1981-02-17|
    PL207570A1|1979-05-21|
    BG28709A3|1980-06-16|
    IT7824490D0|1978-06-13|
    NO149210B|1983-11-28|
    SE7806576L|1978-12-14|
    IT1098216B|1985-09-07|
    CH638202A5|1983-09-15|
    CA1095912A|1981-02-17|
    DD140043A5|1980-02-06|
    YU140078A|1983-01-21|
    FR2394542A1|1979-01-12|
    IL54816D0|1978-07-31|
    ES470750A1|1979-01-16|
    NO149210C|1984-03-07|
    CS204029B2|1981-03-31|
    BE867967A|1978-12-11|
    NO782043L|1978-12-14|
    DK263078A|1978-12-14|
    GB1603958A|1981-12-02|
    NL7806380A|1978-12-15|
    SU860703A1|1981-08-30|
    ATA414478A|1979-12-15|
    JPS569506B2|1981-03-02|
    FI781856A|1978-12-14|
    HU175471B|1980-08-28|
    SE437517B|1985-03-04|
    AU521394B2|1982-04-01|
    AU3683678A|1979-12-06|
    JPS5416487A|1979-02-07|
    FI64156C|1983-10-10|
    DE2825906A1|1979-01-18|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    FR4837M|1964-11-04|
    JPS5831347B2|1975-09-05|1983-07-05|Chugai Pharmaceutical Co Ltd|HU176100B|1977-10-25|1980-12-28|Gyogyszerkutato Intezet|Process for preparing new 3-/1-pyrazolyl/-pyridazine derivatives|
    DE2935359A1|1979-09-01|1981-03-26|Basf Ag, 67063 Ludwigshafen|6-IMIDAZOLYL-3-HYDRAZINO-PYRIDAZINE|
    DE3130251C2|1981-07-31|1989-06-08|A. Nattermann & Cie Gmbh, 5000 Koeln, De|
    US4353905A|1981-09-17|1982-10-12|Warner-Lambert Company|Substituted 4,5-dihydro-6-[4-phenyl]-3-pyridazinones and 6-[4-phenyl]-3-pyridazinones|
    US4590194A|1981-10-05|1986-05-20|Sterling Drug Inc.|3-[methyl or dimethyl)amino]-6-pyridazines and their cardiotonic use|
    US4503056A|1982-03-02|1985-03-05|Abbott Laboratories|1-pyrazoline derivatives|
    DE3825867A1|1988-03-04|1989-09-14|Bayer Ag|HETEROCYCLICALLY SUBSTITUTED SULFONYLAMINOAZOLES AND THEIR USE AS HERBICIDES|
    US5536701A|1994-10-11|1996-07-16|Monsanto Company|3-pyrazolyloxypyridazines, herbicidal compositions and uses thereof|
    EP1565150A1|2002-11-20|2005-08-24|L'oreal|Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof|
    FR2847160A1|2002-11-20|2004-05-21|Oreal|Use of pyrazole-4-carboxamides as 15-hydroxy prostaglandin dehydrogenase inhibitors, e.g. for inducing or stimulating hair growth or inhibiting hair loss|
    ES2375929T3|2005-07-04|2012-03-07|High Point Pharmaceuticals, Llc|HISTAMINE RECEIVER ANTAGONISTS H3.|
    RU2442775C2|2005-07-04|2012-02-20|Хай Пойнт Фармасьютикалс, ЛЛС|Histamine nz-receptor antagonists|
    EP2038256A1|2006-05-23|2009-03-25|TransTech Pharma, Inc|6--2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament|
    EP2402324A1|2006-05-29|2012-01-04|High Point Pharmaceuticals, LLC|Benzodioxolylcyclopropylpiperazinylpyridazines|
    EP2014656A3|2007-06-11|2011-08-24|High Point Pharmaceuticals, LLC|New heteocyclic h3 antagonists|
    AR081331A1|2010-04-23|2012-08-08|Cytokinetics Inc|AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME|
    WO2011133920A1|2010-04-23|2011-10-27|Cytokinetics, Inc.|Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use|
    AR081626A1|2010-04-23|2012-10-10|Cytokinetics Inc|AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    HU77GO1373A|HU175471B|1977-06-13|1977-06-13|Process for producing new 3-bracketul-pyrazolyl-bracket closed-pyridazine derivatives|
    [返回顶部]